Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0000950170-25-028412
Filing Date
2025-02-27
Accepted
2025-02-27 08:50:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B jagx_8-a_20250227.htm 8-A12B 68374
  Complete submission text file 0000950170-25-028412.txt   69483
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-36714 | Film No.: 25673240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)